Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.

    ... syndromes (MDS) are a group of common bone marrow disorders characterized by ineffective hematopoiesis , ... treatment. Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Myelodysplastic syndromes classification and risk stratification.

    ... Myelodysplastic syndromes (MDS) are spectrum of bone marrow failure disorders that share a common pathologic feature: cytologic ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. An update on the treatment of myelodysplastic syndromes.

    ... cytogenetic abnormalities, and the presence of bone marrow blasts . The only potentially curative treatment for MDS is ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Epigenetic therapy in myelodysplastic syndromes.

    ... syndromes (MDS) consist of a family of bone marrow malignancies - with ineffective, inadequate, and dysplastic ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Myelodysplastic syndromes: a practical approach to diagnosis and treatment.

    ... The myelodysplastic syndromes (MDS) are clonal bone marrow disorders that lead to underproduction of normal blood cells. The ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Prognostic classification and risk assessment in myelodysplastic syndromes.

    ... cytogenetics , transfusion dependency, and bone marrow fibrosis . This WHO classification-based Prognostic Scoring ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Deregulation of microRNAs in myelodysplastic syndrome

    ... differentiation of hematopoietic progenitors, bone marrow dysplasia, genetic instability and a propensity to develop acute ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.

    ... and may complement each other by targeting the bone marrow microenvironment and the malignant clone . A recent Phase I ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Myelodysplastic syndromes in older adults.

    ... the hematopoietic development of myeloid cells in the bone marrow . Although this disorder is curable by way of allogeneic stem cell ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.

    ... acute myeloid leukemia with 20% to 30% bone marrow blasts . METHODS: This secondary analysis of the ... MDS. Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 07/20/2018 - 5:14pm.